InsidersTradesSigma
Track the 한미사이언스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 한미사이언스 has logged 36 insider filings. Market capitalisation: €3,101.3bn. The latest transaction was filed on 1 September 2026 (Purchase). Among the most active insiders: 송영숙. Every trade is openly available.
17
Insider Decl.
n/a
Thresholds
€322m
6 ops.
Buy Volume
€82m
3 ops.
Sell Volume
Fundamental score
Ranked 15,799 of 29,114 companies
49.7
score / 100
Value41
Quality59
FCF yld0.9%
Earn yld3.8%
EV/EBITDA21.7x
ROE16%
Gross mgn23%
Net mgn8.7%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 September 2026
Declarations36 total
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
25 of 36 declarations
About 한미사이언스
Hanmi Science is a South Korean company focused on the healthcare and pharmaceutical sector. It is listed on the XKRX market.